Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats

European Journal of Pharmacology

Volumn 364, Issue 2-3, 1999, Pages 159-168

  Squadrito, Francesco ^a   Altavilla, Domenica ^a   Squadrito, Giovanni ^a   Saitta, Antonino ^a   Campo, Giuseppe M ^a   Arlotta, Mariarita ^a   Quartarone, Cristina ^a   Ferlito, Marcella ^a   Caputi, Achille P ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Cyclosporin A; Myocardial ischemia; TNF (tumor necrosis factor )

Indexed keywords

CREATINE KINASE; CYCLOSPORIN A; INTERCELLULAR ADHESION MOLECULE 1; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEMODYNAMICS; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; CREATINE KINASE; CYCLOSPORINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HEMODYNAMIC PROCESSES; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032897260     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00823-1     Document Type: Article

References (30)

1. Arbustini E., Grasso M., Diegoli M., Pucci A., Bramerio M., Ardissino D., Angoli L., De Servi S., Bramucci E., Mussini A., Minzioni G., Vigano M., Specchia G. Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a study. Am. J. Cardiol. 68:1991;368-372.
2. Braquet P., Touqui L., Shen T.Y., Vargaftig G.G. Perspective in platelet activating factor research. Pharmacol. Rev. 39:1987;97-145.
3. Chung M.K., Gulick T.S., Rotondo R.E., Schreiner G.F., Lange L.G. Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes: impairment of signal transduction. Circ. Res. 67:1990;753-763.
4. Clipstone N.A., Crabtrce G.R. Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of immunosuppressive drugs cyclosporin A and FK506. Ann. New York Acad. Sci. 696:1993;20-30.
5. Coker S.J., Parrat J.R. Ah 23848, a thromboxane receptor antagonist suppresses ischemic and reperfusion-induced arrhythmia in anesthetized greyhounds. Br. J. Pharmacol. 86:1985;259-264.
6. Collart M.A., Baeuerle P.A., Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB like motifs of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1990;1498-1506.
7. Dzau V.J. Local contractile and growth modulators in the myocardium. Circ Res. 16:1993;II5-II9. Suppl. II.
8. Feuerstein G. Leukotrienes and the cardiovascular system. Prostaglandin. 27:1984;781-802.
9. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., Simmonds R.L. Negative inotropic effects of cytokine on the heart mediated by nitric oxide. Science. 257:1992;387-389.
10. Fruman, D.A., Burakoff, S.J., Bierer, B.E., 1994. Molecular actions of cyclosporin A, FK 506 and rapamycin. In: Thomson, A.W., Starzl, T.E. (Eds.), Immunosuppressive Drugs: Developments in Anti-rejection Therapy. Edward Arnold, London, pp. 15-35.
11. Hirsh A., Talsness C.E., Schunkert H., Paul M., Dzau V.J. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ. Res. 69:1991;475-482.
12. Hsu S.M., Raine L., Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am. J. Clin. Pathol. 75:1981;734-737.
13. Klein H.H., Pushmann S., Shaper J., Schaper W. The mechanism of the tetrazolium reaction in identifying experimental myocardial infarction. Arch. Pathol. Anat. 393:1981;287-297.
14. Lucchesi B.M. Modulation of leukocyte-mediated myocardial reperfusion injury. Annu. Rev. Physiol. 52:1990;561-566.
15. McCord J.M. Oxygen-derived free radicals in post ischemic tissue injury. New Engl. J. Med. 312:1985;159-163.
16. McMurray J., Abdullah I., Dargie H.J., Shapiro D. Increased concentration of tumor necrosis factor in cachectic patients with severe chronic heart failure. Br. Heart. J. 66:1991;356-360.
17. Massoudy P., Zahler S., Kupatt C., Reder E., Becker B.F., Gerlach E. Cardioprotection by Cyclosporine A in experimental ischemia and reperfusion. Evidence for a nitric oxide-dependent mechanism mediated by endothelin. J. Mol. Cell. Cardiol. 29:1977;535-544.
18. Mullane K.M., Kraemer M.R., Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods. 14:1985;156-157.
19. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor κB: an oxidative stress-responsive transcription factor in eukaryotic cells (a review). Free Radic. Res. Commun. 17:1992;221-237.
20. Schunkert R., Dzau V.J., Tang S.S., Hirsch A.T., Apstein C.S., Loerll B.H. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. J. Clin. Invest. 86:1990;1913-1920.
21. Seekamp A., Till G.O., Mulligan M.S., Paulson J.C., Anderson D.C., Miyasaka M., Ward P.A. Role for selectins in local and remote tissue injury following ischemia and reperfusion. Am. J. Pathol. 144:1994;592-598.
22. Seekamp A., Warren J.S., Remick D.G., Till G.O., Ward P.A. Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/reperfusion and associated lung injury. Am. J. Pathol. 143:1993;464-472.
23. Shandelya S.M., Kuppusamy P., Herskowitz A., Fearon D., Weisfeldt M.L., Zweier J.L. Soluble complement receptor Type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart: evidence that complement activation is required for neutrophil mediated reperfusion injury. Circulation. 88:1993;2812-2826.
24. Squadrito F., Altavilla D., Zingarelli B., Ioculano M., Calapai G., Campo G.M., Caputi A.P. Tumor necrosis factor involvement in myocardial ischaemia-reperfusion injury. Eur. J. Pharmacol. 273:1993;223-250.
25. Squadrito F., Altavilla D., Zingarelli B., Ioculano M., Calapai G., Campo G.M., Miceli A., Prosdocimi M., Caputi A.P. The effects of cloricromene, a cumarine derivative, on leukocyte accumulation, myocardial necrosis and TNF-α production in myocardial ischaemia-reperfusion injury. Life Sci. 53:1993;341-353.
26. Squadrito F., Saitta A., Altavilla D., Ioculano M., Canale P., Campo G.M., Squadrito G., Di Tano G., Mazzu' A., Caputi A.P. Thrombolytic therapy with urokinase reduces increased circulating endothelial adhesion molecules in acute myocardial infarction. Inflamm. Res. 45:1996;14-19.
27. Van der Poll T., Lowry S.F. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock. 3:1995;1-12.
28. Wiederrecht G., Lam E., Hung S., Martin M., Sigal N. The signal mechanisms of action of FK506 and cyclosporin A. Ann. New York Acad. Sci. 696:1993;9-19.
29. Wu C.J., Lovett M., Wong Lee J., Moeller F., Kitamura M., Goralski T.J., Billingham M.E., Starnes V.A., Clayberger C. Citokine gene expression in rejecting cardiac allografts. Transplantation. 54:1990;326-332.
30. Yamada T., Matsumori A., Sasayama S. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation. 89:1994;846-851.